Sg Americas Securities, LLC Aurinia Pharmaceuticals Inc. Transaction History

Sg Americas Securities, LLC

$24.1 Billion
Q2 2025

A detailed history of Sg Americas Securities, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 84,092 shares of AUPH stock, worth $951,921. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,092

Previous 45,243 85.87%

Holding current value

$951,921

Previous $364,000 95.6%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$7.2 - $8.64 $279,712 - $335,655	38,849 Added 85.87%	84,092 $712,000
Q1 2025 Apr 15, 2025	SELL	$7.55 - $8.77 $130,773 - $151,905	-17,321 Reduced 27.69%	45,243 $364,000
Q4 2024 Jan 17, 2025	SELL	$6.75 - $10.44 $3.27 Million - $5.07 Million	-485,163 Reduced 88.58%	62,564 $562,000
Q3 2024 Oct 03, 2024	BUY	$5.32 - $7.33 $2.85 Million - $3.92 Million	535,301 Added 4307.91%	547,727 $4.02 Million
Q2 2024 Jul 12, 2024	SELL	$4.81 - $5.78 $8,484 - $10,195	-1,764 Reduced 12.43%	12,426 $71,000
Q1 2024 May 06, 2024	SELL	$4.93 - $9.31 $103,613 - $195,668	-21,017 Reduced 59.7%	14,190 $71,000
Q4 2023 Jan 12, 2024	BUY	$7.13 - $9.49 $99,998 - $133,097	14,025 Added 66.21%	35,207 $317,000
Q3 2023 Oct 13, 2023	BUY	$7.77 - $12.27 $164,584 - $259,903	21,182 New	21,182 $165,000
Q2 2022 Jul 29, 2022	SELL	$8.95 - $12.8 $6.97 Million - $9.97 Million	-779,071 Reduced 97.24%	22,126 $222,000
Q1 2022 Apr 29, 2022	BUY	$10.05 - $22.48 $1.46 Million - $3.26 Million	144,992 Added 22.1%	801,197 $9.92 Million
Q4 2021 Feb 07, 2022	BUY	$17.78 - $33.08 $4.36 Million - $8.12 Million	245,417 Added 59.74%	656,205 $15 Million
Q3 2021 Nov 01, 2021	BUY	$10.93 - $23.55 $2.66 Million - $5.74 Million	243,678 Added 145.82%	410,788 $9.09 Million
Q2 2021 Aug 12, 2021	BUY	$10.0 - $14.52 $943,780 - $1.37 Million	94,378 Added 129.76%	167,110 $2.17 Million
Q1 2021 May 13, 2021	BUY	$12.3 - $18.73 $894,603 - $1.36 Million	72,732 New	72,732 $944,000
Q1 2020 Apr 30, 2020	SELL	$11.34 - $21.46 $57,890 - $109,553	-5,105 Closed	0 $0
Q4 2019 Jan 28, 2020	SELL	$3.88 - $21.42 $159,114 - $878,412	-41,009 Reduced 88.93%	5,105 $103,000
Q3 2019 Nov 04, 2019	BUY	$5.34 - $6.59 $246,248 - $303,891	46,114 New	46,114 $246,000

Others Institutions Holding AUPH

# of Institutions

243

Shares Held

62.4M

Call Options Held

1.03M

Put Options Held

666K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.61B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Aurinia Pharmaceuticals Inc. Transaction History